William Edward McKechnie - 15 May 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
William McKechnie
Issuer symbol
LEXX
Transactions as of
15 May 2025
Net transactions value
$0
Form type
4
Filing time
16 May 2025, 16:18:27 UTC
Previous filing
30 Jul 2024
Next filing
30 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McKechnie William Edward Director 235 WESTVALE DRIVE, WATERLOO, ONTARIO, CANADA William McKechnie 16 May 2025 0001658613

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 13,191 15 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +11,000 +21% $0.000000 63,000 15 May 2025 Common Shares 11,000 $1.04 Direct
holding LEXX Stock Options 1,500 15 May 2025 Common Shares 1,500 $3.00 Direct
holding LEXX Stock Options 6,500 15 May 2025 Common Shares 5,000 $3.00 Direct
holding LEXX Stock Options 8,400 15 May 2025 Common Shares 1,900 $3.00 Direct
holding LEXX Stock Options 11,800 15 May 2025 Common Shares 3,400 $3.39 Direct
holding LEXX Stock Options 30,000 15 May 2025 Common Shares 18,200 $1.96 Direct
holding LEXX Stock Options 35,000 15 May 2025 Common Shares 5,000 $0.8700 Direct
holding LEXX Stock Options 40,000 15 May 2025 Common Shares 5,000 $2.36 Direct
holding LEXX Stock Options 52,000 15 May 2025 Common Shares 12,000 $3.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.